TR

Trestle Biotherapeutics

YC W21

San Diego, US · Founded 2020 · 2 employees · 2 known investors

trestlebio.com ↗

Trestle Biotherapeutics develops bioengineered implantable tissues designed to treat end-stage renal disease, aiming to get patients off dialysis and eventually provide replacement organs. The company uses stem cell biology, biofabrication, and 3D bioprinting technologies to create functional kidney tissue for patients with kidney failure.

Founders & leadership· Y Combinator alumni (W21)

BS

Ben ShepherdinFounder

AC

Alice CheninFounder

AC

Alice Chen, PhD

BS

Ben Shepherd, PhDCEO

Investors · 2

Y

Y Combinator✓ verifiedSan Francisco · $500K

AX

Axial VCreportedSan Francisco · $100K – $5M

Competitors · 7

by search overlap

LA

Labcentral12 shared keywords

PA

PatSnap10 shared keywordsPatsnap builds an AI-powered platform for R&D, IP, and innovation intelligence, offering tools for patent search, novelty and FTO analysis, patent drafting, and materials and pharma research. It serves R&D leaders, IP professionals, engineers, and scientists across industries including materials, manufacturing, life sciences, pharmaceuticals, and consumer goods.

CO

Cowles_Investments_StemCentrx8 shared keywordsFierce Biotech is a news publication covering the biotechnology, pharmaceutical, and medtech industries, reporting on clinical trials, deals, venture capital, drug development, and research. It serves industry professionals through articles, special reports, events, webinars, and podcasts.

KR

Krystalbio8 shared keywordsKrystal Biotech develops and commercializes redosable gene therapies to treat severe, rare, and life-threatening diseases with limited or no approved treatments. Its first commercial product, VYJUVEK, is a redosable gene therapy for dystrophic epidermolysis bullosa.

DI

Diabetes Prevention Program7 shared keywords

SO

Solu7 shared keywords

ST

Structure Therapeutics7 shared keywords

Companies competing with Trestle Biotherapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.